Growth Metrics

Neuronetics (STIM) Common Equity (2016 - 2026)

Neuronetics has reported Common Equity over the past 11 years, most recently at $13.3 million for Q1 2026.

  • Quarterly Common Equity fell 66.44% to $13.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.3 million through Mar 2026, down 66.44% year-over-year, with the annual reading at $22.4 million for FY2025, 29.63% down from the prior year.
  • Common Equity was $13.3 million for Q1 2026 at Neuronetics, down from $22.4 million in the prior quarter.
  • Over five years, Common Equity peaked at $76.6 million in Q1 2022 and troughed at $9.4 million in Q3 2024.
  • The 5-year median for Common Equity is $34.2 million (2023), against an average of $38.7 million.
  • Year-over-year, Common Equity crashed 75.27% in 2024 and then soared 234.29% in 2025.
  • A 5-year view of Common Equity shows it stood at $57.1 million in 2022, then tumbled by 40.08% to $34.2 million in 2023, then fell by 6.99% to $31.8 million in 2024, then fell by 29.63% to $22.4 million in 2025, then crashed by 40.72% to $13.3 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Common Equity are $13.3 million (Q1 2026), $22.4 million (Q4 2025), and $31.4 million (Q3 2025).